Distributor inventory | Tablet
Glimepiride 3 mg + Metformin Hydrochloride 1000 mg (sustained/extended release)
Type 2 diabetes mellitus when diet and exercise alone are insufficient; helps control high blood sugar in adults
Glimepiride (a sulfonylurea) increases insulin release from the pancreas and improves insulin sensitivity. Metformin reduces glucose production in the liver and decreases intestinal glucose absorption, improving peripheral glucose uptake. Together they lower fasting and post‑meal blood glucose.
Oral tablet. Take exactly as prescribed, usually once daily with food (preferably with the main meal) to reduce stomach upset and risk of low sugar. Swallow whole; do not crush or chew if it is a prolonged/extended-release tablet. Monitor blood glucose regularly.
Common side effects of ZORYL M3 FORTE TAB may include:
Risk of hypoglycaemia (more likely with missed meals, excess exercise, alcohol, elderly, renal/hepatic impairment). Metformin may rarely cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, abdominal pain, or unusual sleepiness. Use with caution in kidney or liver disease; periodic renal function monitoring is required. Temporarily stop metformin before/at iodinated contrast procedures and during major surgery as advised by doctor. Not for type 1 diabetes or diabetic ketoacidosis.
